Caxton Associates (New York)’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-25,524	Closed	-$685K	–	771
2022 Q1	$685K	Buy	25,524 +9,836	+63%	+$264K	0.06%	153
2021 Q4	$748K	Buy	+15,688	New	+$748K	0.08%	154
2021 Q3	–	Sell	-4,931	Closed	-$385K	–	618
2021 Q2	$385K	Buy	+4,931	New	+$385K	0.04%	224